Correlation Between Maat Pharma and Bouygues
Can any of the company-specific risk be diversified away by investing in both Maat Pharma and Bouygues at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Maat Pharma and Bouygues into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Maat Pharma SA and Bouygues SA, you can compare the effects of market volatilities on Maat Pharma and Bouygues and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Maat Pharma with a short position of Bouygues. Check out your portfolio center. Please also check ongoing floating volatility patterns of Maat Pharma and Bouygues.
Diversification Opportunities for Maat Pharma and Bouygues
-0.93 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Maat and Bouygues is -0.93. Overlapping area represents the amount of risk that can be diversified away by holding Maat Pharma SA and Bouygues SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bouygues SA and Maat Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Maat Pharma SA are associated (or correlated) with Bouygues. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bouygues SA has no effect on the direction of Maat Pharma i.e., Maat Pharma and Bouygues go up and down completely randomly.
Pair Corralation between Maat Pharma and Bouygues
Assuming the 90 days trading horizon Maat Pharma SA is expected to under-perform the Bouygues. In addition to that, Maat Pharma is 3.04 times more volatile than Bouygues SA. It trades about -0.11 of its total potential returns per unit of risk. Bouygues SA is currently generating about 0.37 per unit of volatility. If you would invest 2,854 in Bouygues SA on December 30, 2024 and sell it today you would earn a total of 837.00 from holding Bouygues SA or generate 29.33% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Maat Pharma SA vs. Bouygues SA
Performance |
Timeline |
Maat Pharma SA |
Bouygues SA |
Maat Pharma and Bouygues Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Maat Pharma and Bouygues
The main advantage of trading using opposite Maat Pharma and Bouygues positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Maat Pharma position performs unexpectedly, Bouygues can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bouygues will offset losses from the drop in Bouygues' long position.Maat Pharma vs. OSE Pharma SA | Maat Pharma vs. Abivax SA | Maat Pharma vs. Waga Energy SA | Maat Pharma vs. Inventiva SA |
Bouygues vs. Vinci SA | Bouygues vs. Compagnie de Saint Gobain | Bouygues vs. Orange SA | Bouygues vs. Veolia Environnement VE |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |